Document Detail

Evaluation of transthoracic countershock with initial energy levels up to 200 J in a coronary care unit.
MedLine Citation:
PMID:  4031728     Owner:  NLM     Status:  MEDLINE    
In a five year prospective study, transthoracic countershock of patients in the coronary care unit was evaluated with respect to efficacy, transthoracic resistance and arrhythmias. Those patients dying within 12 hours of the recorded event are referred to as agonal patients. Atrial arrhythmias were generally first treated with quinidine or disopyramide and/or a digitalis preparation. Patients with coronary heart disease were treated with lidocaine, disopyramide, or verapamil when there was time for appropriate diagnosis. The efficacy of the first shock with an energy level between 50 J and 200 J in non-agonal patients was: for atrial fibrillation, 44% (N = 34), and between 83% and 93% for tachycardias and ventricular fibrillation. The cumulative efficacy of two shocks with energy levels between 50 J and 200 J was: in atrial fibrillation 53% and others between 90% and 96%. In agonal patients with ventricular fibrillation and acute myocardial infarction the efficacy of one shock of 100-150 J was 39% and two shocks of 100-200 J, 69% (N = 13). No correlation was found between the transthoracic resistance and parameters such as body-weight, length or thorax-circumference, indicating that these should not be taken into account in the choice of the energy level for countershock. In non-agonal patients without coronary heart disease arrhythmias due to countershock increased in duration when the energy of the countershock increased (p less than 0.01, N = 39). It is concluded that the initial stored energy for defibrillation and cardioversion of nonagonal patients in a coronary care unit may be limited to 200 J (160 J delivered energy), even with atrial fibrillation after drug therapy in which case an initial energy level of 200 J seems more appropriate.
R H Geuze; P J de Feijter
Related Documents :
14688688 - Surgery for atrial fibrillation using radiofrequency catheter ablation.
11279408 - Did the introduction of a minimally invasive technique change the incidence of atrial f...
1419968 - Control of collagen fibril diameters in tissues.
14739718 - Role of dofetilide in patients with atrial fibrillation. insights from the symptomatic ...
17161058 - Hemoglobin concentration is an independent determinant of heart failure in acute corona...
24892768 - The relationship between fragmentation on electrocardiography and in-hospital prognosis...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of electrocardiology     Volume:  18     ISSN:  0022-0736     ISO Abbreviation:  J Electrocardiol     Publication Date:  1985 Jul 
Date Detail:
Created Date:  1985-09-30     Completed Date:  1985-09-30     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0153605     Medline TA:  J Electrocardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  251-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arrhythmias, Cardiac / etiology
Atrial Fibrillation / therapy*
Atrial Flutter / therapy*
Coronary Care Units
Coronary Disease / complications
Electric Countershock / methods*
Middle Aged
Ventricular Fibrillation / therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Normal variations in body surface electrocardiographic potential distributions during QRS: effects o...
Next Document:  Sinus node echoes and concealed concealed conduction: additional sinus node phenomena confirmed in m...